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Abstract
BACKGROUND 
Coronary artery vasospasm (CAV) is a reversible, transient form of 
vasoconstriction with clinical manifestations ranging from stable angina to acute 
coronary syndromes (ACS). Vasospasm of epicardial coronary arteries or 
associated micro-vasculature can lead to total or subtotal occlusion and has been 
demonstrated in nearly 50% of patients undergoing angiography for suspected 
ACS. The mechanism for CAV has been described in literature, but in a subgroup 
of patients presenting with intracranial hemorrhage, it appears to be 
multifactorial. These patients tend to have electrocardiographic changes, elevation 
of cardiac biomarkers of injury and neurogenic stress cardiomyopathy.
CASE SUMMARY 
A 44-year-old woman presented with severe headaches and tonic-clonic seizures. 
She was found to have diffuse subarachnoid hemorrhage (SAH) requiring 
ventricular drain placement, coil embolization and induced hypertension. She 
subsequently developed chest pain with ST elevations in anterior precordial leads, 
elevated cardiac enzymes and apical ballooning with left ventricular ejection 
fraction of 35% on transthoracic echocardiogram. Coronary angiogram revealed 
severe diffuse triple vessel stenoses secondary to CAV seen distally. Subsequent 
cardiac MRI notable for apical non-viability and scar formation.
CONCLUSION 
This case highlights a unique etiology of acute myocardial infarction in a patient 
with SAH leading to ST elevations, diffuse triple vessel CAV and apical scar.
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Core Tip: Acute coronary syndromes often occur in patients with multiple co-morbidities 
and treatment plans need to be tailored to each unique presentation. We present a case of 
ST-elevation myocardial infarction in a patient with aneurysmal subarachnoid hemorrhage 
complicated by cerebral and coronary vasospasms, leading to apical infarct.
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INTRODUCTION
Coronary artery vasospasm (CAV) is a reversible, transient form of vasoconstriction 
with clinical manifestations ranging from stable angina to acute coronary syndromes 
(ACS). Vasospasm of epicardial coronary arteries or associated micro-vasculature can 
lead to total or subtotal occlusion and has been demonstrated in nearly 50% of patients 
undergoing angiography for suspected ACS. The mechanism for CAV has been 
described in literature, but in a subgroup of patients presenting with intracranial 
hemorrhage, it appears to be multifactorial[1]. These patients tend to have 
electrocardiographic changes, elevation of cardiac biomarkers of injury and 
neurogenic stress cardiomyopathy[2].
CAV was initially described by Prinzmetal et al[3] in 1959 as a form of variant angina 
different from the heterogeneous group of classical anginal syndromes. A complex 
interplay of mechanisms including increased sympathetic drive to microvascular 
dysfunction have been described in the literature[4]. Here, we present a case of a patient 
with an aneurysmal subarachnoid hemorrhage (SAH) complicated by cerebral 
vasospasm and concomitant severe CAV leading to an acute myocardial infarction 
presenting as ST-elevation myocardial infarction (STEMI) on electrocardiography 
(ECG). While severe CAV is the underlying pathophysiology for stress induced 
cardiomyopathy, acute myocardial infarction (AMI) and apical scarring are rare in 
those cases. There are only a few published case reports in the literature with such 
findings[5-7]. Treatment options are challenging in such cases due to diffuse CAV and 
intracerebral hemorrhage.
CASE PRESENTATION
Chief complaints
Left sided chest pain.
History of present illness
A 44-year-old woman presented to the emergency department with thunderclap 
headache. She was found to have a ruptured cerebral aneurysm and SAH requiring 
neurosurgical intervention. This was followed by severe cerebral vasospasm and 
neurologic deficits treated with induced hypertension using high doses of 
vasopressors. Subsequently she was noted to develop chest pain associated with 
elevated cardiac biomarkers, ST elevation in precordial electrocardiogram leads and 
new apical hypokinesis evident on echocardiogram. This was promptly evaluated 
with a coronary angiogram that demonstrated tapering of distal small caliber coronary 
vessels supplying the territory noted to have wall motion abnormality.
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History of past illness
Hypertension that is controlled on atenolol and hydrochlorothiazide outpatient.
Physical examination
The patient’s heart rate was 97 bpm, respiratory rate was 19 breaths per minute, blood 
pressure was 121/71 mmHg and oxygen saturation on room air was 100%. Cardiac 
examination revealed a regular rate and rhythm, and no jugular venous distention. 
Lung exam revealed clear breath sounds without crackles or wheezing.
Laboratory examinations
Cardiac enzymes with the onset of chest pain showed initial Troponin T at 0.60 ng/mL 
and peaked at 1.72 ng/mL with normal complete blood count and basic metabolic 
panel.
ECG during initial onset of chest pain showed sinus rhythm with ST elevations in 
V3-V5 (Figure 1A). Repeat ECG in the setting of ongoing symptoms showed normal 
sinus rhythm with ST elevations in V1-V3 with deep T-wave inversions in the anterior-
septal leads (Figure 1B).
Imaging examinations
Initial echocardiogram during admission was unremarkable with LVEF 60% and 
normal wall motion. Repeat echocardiogram during STEMI showed a decrease in 
LVEF to 35%-40% with apical ballooning (Figure 2).
Coronary angiography showed patent left main artery, but 100% occlusion of the 
mid to distal left anterior descending artery and distal left circumflex (Figure 3A). 
There was 100% occlusion of the distal posterior descending artery and posterolateral 
artery (Figure 3B). We were unable to give nitrates during left heart catheterization to 
see if the vasospasm would improve as patient was hypotensive and we were 
instructed to keep permissive hypertension by our neurology colleagues. Three weeks 
after the initial angiogram, Cardiac MRI revealed intense delayed enhancement in 
subendocardial fashion involving the apical septum and apical segment suggestive of 
scarred myocardium due to myocardial infarction with LVEF of 58% (Figure 4). We 
believe this to have been an acute MI as baseline ECG did not show q-waves nor was 
there a personal history of MI or symptoms indicative of coronary artery disease 
(CAD) in the past.
Personal and family history
She has a past surgical history of cholecystectomy. She denies alcohol, tobacco, or 
recreational drug use. Family history is positive for hypertension in her parents.
FINAL DIAGNOSIS
ST elevation myocardial infarction secondary to severe coronary artery vasospasm 
causing reduced left ventricular function and apical ballooning.
TREATMENT
After the coronary angiogram, dual antiplatelet therapy and nitrates were added to 
her regimen to help reduce CAV. Her discharge medications included aspirin 81 mg 
daily, carvedilol 3.25 mg BID, atorvastatin 40 mg qhs, clopidogrel 75 mg daily, 
isosorbide mononitrate 30 mg daily and nitroglycerin sublingual as needed.
OUTCOME AND FOLLOW-UP
Patient follows up regularly with our cardiology clinic. She’s doing well with good 
exercise tolerance and remains angina free. Her systolic function remains persistently 
borderline with 50% EF and apical wall motion suggestive of apical infarct three 
months after her hospital discharge.
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Figure 1  Electrocardiogram. A: Electrocardiogram (ECG) showing ST elevations in leads V3-V5, and evidence of left ventricular hypertrophy with repolarization 
abnormality and prolonged QTc. B: ECG showing normal sinus rhythm with ST elevations in V1-V3 with deep T-wave inversions in the anterior-septal leads.
Figure 2  Echocardiogram on HD 16 showing apical ballooning.
DISCUSSION
We present a rare case of severe CAV leading to apical infarct and low-normal EF in 
setting of SAH and induced hypertension employed for its treatment. To our 
knowledge, this is the first case describing the coronary findings in a patient with SAH 
and apical infarct on CMR.
The typical pathogenesis for myocardial ischemia involves coronary artery 
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Figure 3  Coronary angiogram. A: Coronary angiogram shows severely atretic distal left anterior descending artery and obtuse marginal coronary arteries; B: 
The posterolateral and posterior descending artery branches of the right coronary artery are severely narrowed distally.
Figure 4  Cardiac magnetic resonance imaging shows delayed gadolinium enhancement suggestive of apical scarring and nonviability.
atherosclerosis and/or plaque rupture[8]. Our patient had minimal risk factors for CAD 
and suffered an acute myocardial infarction due to severe CAV which is known to be 
triggered by high sympathetic drive in patients with SAH. It is believed that excessive 
sympathetic drive in such cases lead to mismatch in myocardial oxygen demand and 
supply leading to neurogenic stunned myocardium (NSM)[9,10].
Neurogenic myocardial stunning has been described frequently in medical 
literature and is described as a state of reversible left ventricular dysfunction that 
occurs in up to 30% of patients with SAH. Echocardiographic manifestations of 
Takotsubo cardiomyopathy can be found in 1% to 6% of SAH patients with CAV being 
one of the underlying mechanisms[10,11]. Overall involvement of myocardium and the 
incidence and description of SAH complicated by cerebral and coronary vasospasm is 
seldom described in literature[12]. Animal studies have shown when blood is injected 
into the subarachnoid space, it is associated with increased amounts of coronary 
vasospasm in the subjects due to vagal pathway paralysis induced by sympathetic 
overactivity[13]. This sympathetic overactivity can also occur as a result of rising 
intracranial pressures from SAH due to increased secretion of cerebrospinal fluid 
triggered by hemorrhage[14,15]. Elevated catecholamine levels can be linked to cerebral 
vasospasms and have been associated with left ventricular dysfunction[11]. Therapy for 
cerebral vasospasm includes hypervolemia and induced hypertension, which may 
further result in potential cardiopulmonary complications like myocardial ischemia 
and pulmonary edema[16]. Proposed interventions like mechanical circulatory-assist 
devices with intra-aortic balloon pump have been shown to be successful for isolated 
patients with severe myocardial dysfunction complicated by cerebral vasospasms, but 
has not been studied thoroughly in this patient population[17].
Incidence of CAV in the setting of ACS has been studied with varying percentages 
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of frequency based off populations studied. In a Taiwanese population, patients 
suspected to have coronary ischemia underwent coronary angiograms with findings of 
non-obstructive CAD, but ergonovine provocation testing was positive in 41% of 
patients[18]. In a French study, Caucasian patients being worked up for acute MI 
showed CAV positive in only 15.5% of patients[19]. Diagnosis and treatment of CAV has 
been well described in literature, but data in SAH remains scarce. Some research has 
been attempted in this area, in which prophylactic beta-blockers were hypothesized to 
reduce catecholaminergic surges in order to reduce the incidence and complications 
that arise from NSM, but a meta-analysis by Luo et al[20] showed no statistical benefit to 
this therapy. Clinical evidence is widespread for CAV and treatment modalities using 
nitrates and calcium-channel blockers; however, in the subset of patients complicated 
by SAH, there is limited data regarding acute cardioprotective strategies[3].
Our patient was empirically treated with heparin infusion, aspirin therapy and 
calcium channel blocker (nimodipine) and was not taken to the catheterization lab 
immediately due to suspicion for coronary vasospasm due to SAH and high doses of 
vasopressor use. However, in order to attain a definitive cardiac diagnosis, the 
angiogram was done showing diffuse epicardial CAV resulting in her cardiomyopathy 
and evidence of myocardial infarction seen on CMR. Her delayed enhancement seen 
on CMR with wall motion abnormalities was intense and in subendocardial fashion 
which is indicative of an MI than stress induced cardiomyopathy like Takotsubo, 
which generally leads to little midmyocardial or patchy delayed enhancement. Due to 
permissive hypertension requirement from neurology colleagues, her initial 
management of MI was tricky. Once her symptoms resolved, she was initiated on 
guidelines directed medical therapy of cardio selective beta-blocker and antiplatelets. 
Scarcity of medical literature relevant to this specific clinical scenario calls for 
individualized management approach. As we identify large percentage of patients 
with SAH and electrocardiographic abnormalities, elevated cardiac biomarkers and 
wall motion abnormalities, more data on how to carefully proceed with risk 
stratification, diagnosing and treating acute coronary syndromes in this population is 
needed[4].
CONCLUSION
Severe diffuse coronary artery vasospasm can lead to myocardial dysfunction and 
acute myocardial infarction in patients with SAH. Further research is needed to 
understand coronary vasospasm happening concomitantly with cerebral vasospasm in 
order to attenuate consequences of severe CAV and develop cardioprotective 
strategies to minimize end-organ damage.
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